DNA Nanobots
- 25/01/2024
- Pre-Seed
- Undisclosed Amount
With a portfolio of existing IP, DNA Nanobots develops products for point-of-care therapeutics, functionalized gene delivery, and diagnostics. We also provide product development services and expertise in the functionalization of DNA nanotechnology with experience in Gene Delivery, Vaccine Development, Targeted Drug Delivery and Nucleic acid diagnostic testing.
- Industry Nanotechnology Research
- Website https://dnananobots.com/
- LinkedIn https://www.linkedin.com/company/dnananobots/
Related People
Jeff SpitznerFounder
Over 20 years’ experience as a founder and executive of nine Life Sciences, Software, Investment, Bio-Technology, and Healthcare companies that contributed over $35 Million to the Columbus, OH community. Technology business leadership focused on growth and innovation. Spitzner won the 2011 Executive of the Year Innovation Award.
Business Skills Include:
• Product Visionary •Technology Commercialization • Business Development
• Investment Analysis • Strategic Marketing and Technology Direction
• Product Management & Development • Investment Fundraising & Analysis
• Sales Management • Strategic Partnering • Executive Leadership
• Building a Winning Team and Culture • Consulting
Focus: Company formation/growth & bringing innovative products from concept to market.
Numerous publications, invited conference presentations and interviews, and industry awards. Ph.D. Ohio State (molecular cancer research), postdoc Massachusetts Institute of Technology (MIT).
Spitzner raised over $20 Million in investment, over $7 Million in grant and non-dilutive capital funding, and created over 90 new jobs. Highlights: as CEO, led sales growth of enterprise software by 300% to >100 enterprise customers. Sold Visual Genomics for $5 Million exit. Innovative tech (XML 1997, semantic web 2002, genome informatics 2001).
Now: Leading Amperand Consulting, CEO of Med techs, new business opportunities.